|
WLL
WLL
Wellco Health Limited - Dealing in securities by a director of a subsidiary
Wellco Health Limited
(formerly Nungu Trading 279 (Pty) Ltd)
(Incorporated in the Republic of South Africa)
(Registration number 2005/005805/06)
Share code: WLL & ISIN: ZAE000071841
("Wellco" or "the company")
DEALING IN SECURITIES BY A DIRECTOR OF A SUBSIDIARY
In terms of paragraphs 3.63 - 3.74 of the Listings Requirements of the JSE
Limited shareholders are advised that the following information relating to
share dealings by a director of a subsidiary of Wellco is accordingly disclosed:
Director: Gcina Wiseman Mtshali
Company: Wellco Brands (Pty) Ltd
Date of transaction: 06 July 2006
Class of securities: Ordinary shares
Number of securities: 14 000
Price per share: 40 cents
Total value: R5 600
Nature of transaction: Sell
Nature and extent of director"s interest: Direct and beneficial
Director: Gcina Wiseman Mtshali
Company Wellco Brands (Pty) Ltd
Date of transaction: 06 July 2006
Class of securities: Ordinary shares
Number of securities: 30 000
Price per share: 39 cents
Total value: R11 700
Nature of transaction: Sell
Nature and extent of director"s interest: Direct and beneficial
Director: Gcina Wiseman Mtshali
Company: Wellco Brands (Pty) Ltd
Date of transaction: 11 July 2006
Class of securities: Ordinary shares
Number of securities: 340 000
Price per share: 37 cents
Total value: R125 800
Nature of transaction: Sell
Nature and extent of director"s interest: Direct and beneficial
Director: Gcina Wiseman Mtshali
Company: Wellco Brands (Pty) Ltd
Date of transaction: 11 July 2006
Class of securities: Ordinary shares
Number of securities: 14 632
Price per share: 40 cents
Total value: R5 852
Nature of transaction: Sell
Nature and extent of director"s interest: Direct and beneficial
Clearance to sell these shares have been given in terms of rule 3.66 of the JSE
Listings Requirements.
11 July 2006
Pretoria
Designated Advisor
River Group
Warning: The listing of ordinary shares in the company is on the AltX.
Shareholders are advised of the risks of investing in a company listed on the
AltX. Shareholders are advised that the JSE does not guarantee the viability or
the success of a company listed on the AltX. In terms of the JSE Listings
Requirements a Designated Advisor has to be retained by the company. The
Designated Advisor is required to, inter alia, attend all board meetings held by
the company to ensure that all JSE Listings Requirements and applicable
regulations are complied with, approve the financial director of the company and
guide the company in a competent, professional and impartial manner. If the
company fails to retain a Designated Advisor it must make arrangement to appoint
a new Designated Advisor within 10 business days, failing which the company
faces suspension of trading of its securities. If a Designated Advisor is not
appointed within 30 days of its suspension the company faces the termination of
its listing without an offer to minority shareholders.
Date: 11/07/2006 05:05:06 PM Produced by the JSE SENS Department
| Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information. | |||||||||||||
| Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site | |||||||||||||
| [ Terms of Use | Privacy Policy | PAIA manual | FAQs/Help | Site Map | © Copyright Reserved 2026 ] | |||||||||||||
|
|||||||||||||
